Biogen IDEC biogen.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145) Eye Health (696)

IDEC Pharmaceuticals Corporation is engaged in the development of targeted immunotherapies for cancer and autoimmune diseases. The company's products act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient's blood or lymphatic system. Founded in 1978, Biogen Idec is involved in the discovery, development, manufacturing, and commercialization of innovative therapies. The company was formed through the June 2003 me...Show all

IDEC Pharmaceuticals Corporation is engaged in the development of targeted immunotherapies for cancer and autoimmune diseases. The company's products act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily ...Show all

Company (Alive / Active)

Phone: 781-464-2000

Fax:



Cambridge, 02138
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Biogen IDEC $0M Feb 18, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Biogen IDEC Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Factor ix polypeptides and methods of use thereof Dec 29, 2015 Jan 16, 2018 Patent
Lingo-2 antagonists for treatment of conditions involving motor neurons May 14, 2013 Oct 24, 2017 Patent
S1p and/or atx modulating agents Nov 20, 2013 Sep 26, 2017 Patent
Anti-α Jul 28, 2014 Aug 29, 2017 Patent
Cognitive composite parameters and uses thereof for evaluating multiple sclerosis Apr 19, 2013 Aug 01, 2017 Patent
See all 311 patents